Watermark Asset Management’s Xtrackers MSCI Emerging Markets Hedged Equity ETF DBEM Stock Holding History

Watermark Asset Management’s Portfolio DBEM Stock Details DBEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$10K	Buy	+460	New	+$9.95K	﹤0.01%	165

Other funds holding DBEM

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

UWM

USAdvisors Wealth Management Eden Prairie, Minnesota $301M AUM 15.03% 1-Year Est. Return

Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return

Watermark Asset Management's DBEM Position: Q4 2018 in Review

Watermark Asset Management opened a new position in Xtrackers MSCI Emerging Markets Hedged Equity ETF (DBEM) in Q4 2018: 460 shares worth $10K. The stake represents ﹤0.01% of the portfolio and ranks #165 among its holdings.

40 funds tracked by Wall St. Rank hold DBEM as of Q4 2018.

Watermark Asset Management held 460 shares of Xtrackers MSCI Emerging Markets Hedged Equity ETF worth $10K as of Q4 2018.
Xtrackers MSCI Emerging Markets Hedged Equity ETF was a new Watermark Asset Management position in Q4 2018.
Xtrackers MSCI Emerging Markets Hedged Equity ETF made up ﹤0.01% of Watermark Asset Management's portfolio in Q4 2018, its #165 holding.
40 funds tracked by Wall St. Rank held Xtrackers MSCI Emerging Markets Hedged Equity ETF as of Q4 2018.

Based on Watermark Asset Management's 13F filing for Q4 2018, filed 14 Jan 2019.